Share-based Payment Arrangement, Expense of Praxis Precision Medicines, Inc. from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Praxis Precision Medicines, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • Praxis Precision Medicines, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $9,938,000, a 16% increase year-over-year.
  • Praxis Precision Medicines, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $33,941,000, a 18% decline year-over-year.
  • Praxis Precision Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $33,941,000, a 18% decline from 2024.
  • Praxis Precision Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $41,360,000, a 66% increase from 2023.
  • Praxis Precision Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $24,857,000, a 13% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Praxis Precision Medicines, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $33,941,000 $9,938,000 +$1,363,000 +16% 01 Oct 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $32,578,000 $7,447,000 -$4,985,000 -40% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $37,563,000 $7,770,000 +$1,892,000 +32% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $35,671,000 $8,786,000 -$5,689,000 -39% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $41,360,000 $8,575,000 +$2,849,000 +50% 01 Oct 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $38,511,000 $12,432,000 +$6,669,000 +116% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $31,842,000 $5,878,000 +$103,000 +1.8% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025 2025 Q2
Q1 2024 $31,739,000 $14,475,000 +$6,882,000 +91% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q4 2023 $24,857,000 $5,726,000 -$640,000 -10% 01 Oct 2023 31 Dec 2023 10-K 19 Feb 2026 2025 FY
Q3 2023 $25,497,000 $5,763,000 -$967,000 -14% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $26,464,000 $5,775,000 -$1,836,000 -24% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $28,300,000 $7,593,000 -$293,000 -3.7% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $28,593,000 $6,366,000 +$260,000 +4.3% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $28,333,000 $6,730,000 +$209,000 +3.2% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $28,124,000 $7,611,000 +$2,211,000 +41% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $25,913,000 $7,886,000 +$3,220,000 +69% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $22,693,000 $6,106,000 +$2,280,000 +60% 01 Oct 2021 31 Dec 2021 10-K 07 Feb 2023 2022 FY
Q3 2021 $20,413,000 $6,521,000 +$5,568,000 +584% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $14,845,000 $5,400,000 +$5,115,000 +1795% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $9,730,000 $4,666,000 +$4,519,000 +3074% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $5,211,000 $3,826,000 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $953,000 +$677,000 +245% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $285,000 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $147,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 $276,000 01 Jul 2019 30 Sep 2019 10-Q 23 Nov 2020 2020 Q3

Praxis Precision Medicines, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $33,941,000 -$7,419,000 -18% 01 Jan 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
2024 $41,360,000 +$16,503,000 +66% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
2023 $24,857,000 -$3,736,000 -13% 01 Jan 2023 31 Dec 2023 10-K 19 Feb 2026 2025 FY
2022 $28,593,000 +$5,900,000 +26% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $22,693,000 +$17,482,000 +335% 01 Jan 2021 31 Dec 2021 10-K 07 Feb 2023 2022 FY
2020 $5,211,000 +$4,543,000 +680% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $668,000 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.